More importantly, we found that in younger individuals without PCa, elevated biological aging acceleration was significantly associated with an increased early risk of PCa as defined by PSA levels, which can identify treatable early-stage PCa, significantly reducing disease-specific mortality and improving the detection of asymptomatic, well-differentiated PCa [26, 27]. Here, KLK3 is linked to posterior cortical atrophy.